CYTEK BIOSCIENCES, INC. (CTKB) Gross margin 2020–2025
CYTEK BIOSCIENCES, INC. (CTKB) gross margin by fiscal year — reported gross profit divided by reported revenue.
51.8%FY2025 · since FY2020: 55.7% → 51.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 51.8% | -3.6 pp |
| FY2024 | 55.4% | -1.3 pp |
| FY2023 | 56.7% | -4.9 pp |
| FY2022 | 61.6% | -0.3 pp |
| FY2021 | 61.9% | +6.2 pp |
| FY2020 | 55.7% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CTKB financial trends
CTKB RevenueCTKB Net incomeCTKB Net marginCTKB Gross profitCTKB Operating incomeCTKB Operating marginCTKB Operating cash flowCTKB Free cash flowCTKB Capital expendituresCTKB Return on equityCTKB Stock buybacksCTKB Dividends paidCTKB Total assetsCTKB Total liabilitiesCTKB Shareholders’ equityCTKB overview →